203 related articles for article (PubMed ID: 26903297)
1. Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
Aibibula Z; Ailixiding M; Iwata M; Piao J; Hara Y; Okawa A; Asou Y
Biochem Biophys Res Commun; 2016 Mar; 472(1):26-32. PubMed ID: 26903297
[TBL] [Abstract][Full Text] [Related]
2. Initial responses of articular tissues in a murine high-fat diet-induced osteoarthritis model: pivotal role of the IPFP as a cytokine fountain.
Iwata M; Ochi H; Hara Y; Tagawa M; Koga D; Okawa A; Asou Y
PLoS One; 2013; 8(4):e60706. PubMed ID: 23593289
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic Functions of High Fat Diet in the Etiology of Osteoarthritis.
Asou Y; Iwata M; Ochi H; Ailixiding M; Aibibula Z; Piao J; Jin G; Hara Y; Okawa A
PLoS One; 2016; 11(9):e0162794. PubMed ID: 27611831
[TBL] [Abstract][Full Text] [Related]
5. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
[TBL] [Abstract][Full Text] [Related]
6. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics.
Nomura J; Kobayashi T; So A; Busso N
Sci Rep; 2019 Nov; 9(1):17314. PubMed ID: 31754153
[TBL] [Abstract][Full Text] [Related]
8. Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice.
Nakamura T; Murase T; Nampei M; Morimoto N; Ashizawa N; Iwanaga T; Sakamoto R
Eur J Pharmacol; 2016 Jun; 780():224-31. PubMed ID: 27038523
[TBL] [Abstract][Full Text] [Related]
9. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
Chen C; Lü JM; Yao Q
Med Sci Monit; 2016 Jul; 22():2501-12. PubMed ID: 27423335
[TBL] [Abstract][Full Text] [Related]
10. Increased synovial lipodystrophy induced by high fat diet aggravates synovitis in experimental osteoarthritis.
Larrañaga-Vera A; Lamuedra A; Pérez-Baos S; Prieto-Potin I; Peña L; Herrero-Beaumont G; Largo R
Arthritis Res Ther; 2017 Dec; 19(1):264. PubMed ID: 29191221
[TBL] [Abstract][Full Text] [Related]
11. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
[TBL] [Abstract][Full Text] [Related]
12. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance.
Reynolds CM; McGillicuddy FC; Harford KA; Finucane OM; Mills KH; Roche HM
Mol Nutr Food Res; 2012 Aug; 56(8):1212-22. PubMed ID: 22700321
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidoreductase and its inhibitors: relevance for gout.
Day RO; Kamel B; Kannangara DR; Williams KM; Graham GG
Clin Sci (Lond); 2016 Dec; 130(23):2167-2180. PubMed ID: 27798228
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities.
Harmon DB; Mandler WK; Sipula IJ; Dedousis N; Lewis SE; Eckels JT; Du J; Wang Y; Huckestein BR; Pagano PJ; Cifuentes-Pagano E; Homanics GE; Van't Erve TJ; Stefanovic-Racic M; Jurczak MJ; O'Doherty RM; Kelley EE
Diabetes; 2019 Jun; 68(6):1221-1229. PubMed ID: 30936145
[TBL] [Abstract][Full Text] [Related]
15. Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.
Finucane OM; Lyons CL; Murphy AM; Reynolds CM; Klinger R; Healy NP; Cooke AA; Coll RC; McAllan L; Nilaweera KN; O'Reilly ME; Tierney AC; Morine MJ; Alcala-Diaz JF; Lopez-Miranda J; O'Connor DP; O'Neill LA; McGillicuddy FC; Roche HM
Diabetes; 2015 Jun; 64(6):2116-28. PubMed ID: 25626736
[TBL] [Abstract][Full Text] [Related]
16. High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury.
Warmink K; Kozijn AE; Bobeldijk I; Stoop R; Weinans H; Korthagen NM
Osteoarthritis Cartilage; 2020 May; 28(5):593-602. PubMed ID: 32222415
[TBL] [Abstract][Full Text] [Related]
17. Uric acid secretion from adipose tissue and its increase in obesity.
Tsushima Y; Nishizawa H; Tochino Y; Nakatsuji H; Sekimoto R; Nagao H; Shirakura T; Kato K; Imaizumi K; Takahashi H; Tamura M; Maeda N; Funahashi T; Shimomura I
J Biol Chem; 2013 Sep; 288(38):27138-27149. PubMed ID: 23913681
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1
Ohata K; Kamijo-Ikemori A; Sugaya T; Hibi C; Nakamura T; Murase T; Oikawa T; Hoshino S; Katayama K; Asano J; Kimura K; Shibagaki Y
Eur J Pharmacol; 2017 Nov; 815():88-97. PubMed ID: 28888756
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.
Honda H; Nagai Y; Matsunaga T; Okamoto N; Watanabe Y; Tsuneyama K; Hayashi H; Fujii I; Ikutani M; Hirai Y; Muraguchi A; Takatsu K
J Leukoc Biol; 2014 Dec; 96(6):1087-100. PubMed ID: 25210146
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
